The collaboration applies Concerto's full stack data generation and AI platform to Sacco System's microbial collections CAMBRIDGE, Mass., Jan. 29, 2026 /PRNewswire/ -- Concerto Biosciences®, the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Concerto Biosciences, a biotechnology company designing microbial communities that restore deficient microbiomes to treat disease, announced today that it raised $23 ...
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a ...